Personalis, Inc. Common Stock (PSNL) Stock
NASDAQ · PSNL
16.40
Fundamentals
Market cap
$1.75B
Price / Earnings ratio
-16.2x
Price / Sales ratio
24.9x
Price / Book ratio
7.4x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Personalis, Inc. Common Stock
No description available.
SectorHealthcare
IndustryDiagnostics & Research
Employees259
CEOMr. Christopher M. Hall
IPO DateJun 20, 2019
HeadquartersFremont, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Christopher M. Hall | CEO & Director | 1969 |
| Dr. Richard Chen M.D., M.S. | President & Chief Medical Officer | 1971 |
| Mr. Aaron L. Tachibana | CFO & COO | 1961 |
| Dr. Russ B. Altman M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | — |
| Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | 1971 |
| Dr. Michael P. Snyder Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board | — |
| Mr. Ashish Kheterpal | Senior VP & Chief Information Officer | — |
| Mr. Stephen M. Moore J.D. | Senior VP, Chief Legal Officer & Corporate Secretary | 1972 |
| Dr. Christian Haudenschild Ph.D. | Senior Vice President of Genomic Science | — |
| Mr. Stephane Mouradian Ph.D. | Senior Vice President of Business Development | — |
Fundamentals
Valuation
Market cap$1.75B
Price-to-sales ratio24.88
Price-to-book value7.37
Price-earnings ratio-16.20
Return on Equity-44.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.09
Income Statement
Average volume3,821,092
EBITDA$-84.37M
1 year high (52w)$18.89
1 year low (52w)$4.96
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



